Ming Zeng

Camrelizumab versus investigator's choice of chemotherapy as second-line therapy for advanced or metastatic oesophageal squamous cell carcinoma (ESCORT): a multicentre, randomised, open-label, phase 3 study

Jing Huang, Jianming Xu, Yun Chen et al. · The Lancet Oncology · 2020 · 584 citations

Medicine, Oncology, Pharmacology +14

Efficacy, safety, and immunogenicity of an oral recombinant Helicobacter pylori vaccine in children in China: a randomised, double-blind, placebo-controlled, phase 3 trial

Ming Zeng, Xuhu Mao, Jingxin Li et al. · The Lancet · 2015 · 294 citations

Veterinary Medicine, Immunology, Pediatrics +12

Randomized Trial of First-Line Tyrosine Kinase Inhibitor With or Without Radiotherapy for Synchronous Oligometastatic <i>EGFR</i>-Mutated Non-Small Cell Lung Cancer

Xiaoshan Wang, Yifeng Bai, Vivek Verma et al. · JNCI Journal of the National Cancer Institute · 2022 · 255 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Efficacy of Concurrent Chemoradiotherapy With S-1 vs Radiotherapy Alone for Older Patients With Esophageal Cancer

Yongling Ji, Xianghui Du, Weiguo Zhu et al. · JAMA Oncology · 2021 · 110 citations · Full text

Medicine, Oncology, Radiation Oncology +16

Functional Characterization of a Flavonoid Glycosyltransferase in Sweet Orange (Citrus sinensis)

Xiaogang Liu, Cailing Lin, Xiaodi Ma et al. · Frontiers in Plant Science · 2018 · 104 citations · Full text

Life Sciences, Biochemistry, Plant Biology +17